Canine Pemphigus Complex: Pathogenesis and Clinical Presentation

Compendium on Continuing Education for the Practicing Veterinarian

Volumn 22, Issue 6, 2000, Pages 568-572

  Marsella, Rosanna ^a  

^a UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0348236957     PISSN: 01931903     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Wurm S, Mattise AW, Dunstan RW: Comparative pathology of pemphigus in dogs and humans. Clin Dermatol 12: 515-524, 1994.
2. Amagai M: Autoantibodies against cell adhesion molecules in pemphigus. J Dermatol 21:833-837, 1994.
3. Suter MM, Ziegra C, Cayatte SM, et al: Identification of canine pemphigus antigens, in Ihrke PJ, Mason IS, White SD (eds): Advances in Veterinary Dermatology II. New York, Pergamon Press, 1993, pp 367-369.
4. Squiquera HL, Diaz LA, Sampaio SAP, et al: Serologic abnormalities in patients with endemic pemphigus foliaceus (fogo selvagem), their relatives, and normal donors from endemic and nonendemic areas of Brazil. J Invest Dermatol 91:189-191, 1988.
5. Anhalt GJ, Labib RS, Voorhees JJ, et al: Induction of pemphigus in neonatal mice by passive transfer of IgG from patients with the disease. N Engl J Med 306:1189-1196, 1982.
6. Storer JS, Galen WK, Nesbitt LT, et al: Neonatal pemphigus vulgaris. J Am Acad Dermatol 6:929-932, 1982.
7. Schiltz JR, Michel B: Production of epidermal acantholysis in normal human skin in vitro by the IgG fraction from pemphigus sera. J Invest Dermatol 67:254-260, 1976.
8. Burge SM, Wilson CL, Dean D, Wojnarowska F: An immunohistological study of desmosomal components in pemphigus. Br J Dermatol 128:363-370, 1993.
9. Iwatsuki K, Harada H, Yokote R, Kaneko F: Differences in the expression of pemphigus antigens during epidermal differentiation. Br J Dermatol 133:209-216, 1995.
10. Hashimoto K, Shafran KM, Webber PS, et al: Anticell surface pemphigus autoantibody stimulates plasminogen activator activity of human epidermal cells: A mechanism for the loss of epidermal cohesion and blister formation. J Exp Med 157:259-272, 1983.
11. Naito K, Morioka S, Nakajima S, Ogawa H: Proteinase inhibitors block formation of pemphigus acantholysis in experimental models of neonatal mice and skin explants: Effects of synthetic and plasma proteinase inhibitors on pemphigus acantholysis. J Invest Dermatol 93:173-177, 1989.
12. Quigley JP, Gold LI, Schwimmer R, Sullivan LM: Limited cleavage of cellular fibronectin by plasminogen activator purified by transformed cells. Proc Natl Acad Sci U S A 84: 2776-2780, 1987.
13. Wilkinson E, Smith CA, Suter MM, et al: Role of plasminogen activator in pemphigus vulgaris. Am J Pathol 134(3): 561-569, 1989.
14. Anhalt GJ, Till GO, Diaz LA: Defining the role of complement in experimental pemphigus vulgaris in mice. J Immunol 137:2835-2840, 1986.
15. Honeyman JF, Eguiguren G, Pinto A, et al: Bullous dermatoses of pregnancy. Arch Dermatol 117:264-267, 1981.
16. Anhalt GJ, Kim SC, Stanley JR, et al: Paraneoplastic pemphigus. N Engl J Med 323:1729-1735, 1990.
17. Brenner S, Wolf R, Ruocco V: Drug induced pemphigus. A survey. Clin Dermatol 11:501-505, 1993.
18. Brenner S, Wolf R: Possible nutritional factors in induced pemphigus. Dermatology 189:337-339, 1994.
19. Ruocco V, Wolf R, Ruocco E: Viruses in pemphigus. A casual or causal relationship? Int J Dermatol 35:782-784, 1996.
20. Brenner S, Bar-Natan EA: Pemphigus vulgaris triggered by emotional stress. J Am Acad Dermatol 11:524-525, 1984.
21. Brenner S, Wolf R: Contact pemphigus: A subgroup of induced pemphigus. Int J Dermatol 33:843-845, 1994.
22. Lemmens P, De Bruin A, Meulemeester J, et al: Paraneoplastic pemphigus in a dog. Vet Dermatol 9:127-134, 1998.
23. Noli C, Kolman JP, Willemse T: A retrospective evaluation of adverse reactions to trimethoprim-sulphonamide combinations in dogs and cats. Vet Q 17(4):123-128, 1995.
24. Wolf R, Ruocco V: Gaining more insight into the pathomechanisms of thiol-induced acantholysis. Med Hypotheses 48: 107-110, 1997.
25. Ihrke PJ, Stannard AA, Ardans AA, Griffin CE: Pemphigus foliaceus in dogs: A review of 37 cases. JAVMA 186:59-66, 1985.
26. Scott DW: Pemphigus vegetans in a dog. Cornell Vet 67(3): 374-384, 1977.
27. Friedman H, Campbell I, Rocha-Alvarez R, et al: Endemic pemphigus foliaceus (fogo selvagem) in native Americans from Brazil. J Am Acad Dermatol 32:949-956, 1995.
28. Pascal A, Shiebert J, Ihrke P: Seasonality and environmental risk factors for pemphigus foliaceous in animals: A retrospective study of 83 cases presented to the Veterinary Medical Teaching Hospital, University of California, Davis, from 1976 to 1994. Proc Ann Meet Am Acad Vet Dermatol Am Coll Vet Dermatol:24-25, 1995.
29. Scott DW, Miller WH, Griffin CE: Small Animal Dermatology. Philadelphia, WB Saunders Co, 1995, pp 484-627.
30. Dugan EM, Anhalt G, Diaz LA: Pemphigus, in Jordan RE (ed): Immunologic Diseases of the Skin. Norwalk, CT, Appleton & Lange, 1991, pp 279-291.
31. Suter M: Pemphigus vulgaris and pemphigus foliaceus in dogs: 9 cases. Schweiz Arch Tierheilkd 126(5):249-260, 1984.
32. Mattise AW: Canine pemphigus vegetans: A report of 16 cases. Proc Ann Meet Am Acad Vet Dermatol Am Coll Vet Dermatol 7:28, 1991.
33. Scott DW, Miller Jr WH, Lewis RM, et al: Pemphigus erythematosus in the dog and cat. JAAHA 16:815-823, 1980.
34. DeBruin A, Muller E, Wyder M, et al: Periplakin and envoplakin are target antigens in canine and human paraneoplastic pemphigus. J Am Acad Dermatol 40:682-685, 1999.